Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezacaftor and Ivacaftor in Children 6-11 with Cystic Fibrosis
NCT02953314Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Nov 2016
- Primary completion
- Sep 2018
- Countries
- 2
01
Overview
Phase 3, open-label trial of tezacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Nov 2016; status: completed.
02
Drugs
tezacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02953314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953314.